The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes

Marie Febvre-James(Inserm), Olivier Fardel(Centre Hospitalier Universitaire de Rennes)
Drug Metabolism and Disposition
November 21, 2017
Cited by 41


Related Papers